Alternatives to CryoPort

A clinical-stage biotechnology company developing in vivo gene editing therapies.

Develops and markets bioproduction tools for cell and gene therapy manufacturing and distribution.

Accelerating the development of breakthrough new medicines and medical technologies.

Global leader in serving science, providing analytical instruments, consumables, and services for research, diagnostics, and manufacturing.

Global leader in life sciences, diagnostics, and applied chemical markets.

Moderna is a biotechnology company pioneering mRNA medicine, best known for its COVID-19 vaccine and a broad pipeline of mRNA-based therapeutics.

Designs proteins with superior properties using computational analysis, evolutionary insights, and AI.

Omec.ai is a life sciences startup focused on accelerating drug discovery and development through AI.

Quantum software company enabling breakthroughs in chemistry, materials science, and life sciences.

An accelerator program for life science startups.

A global leader in clinical pharmacology and bioanalytical sciences.

H1 is a healthcare data platform that connects life sciences companies with healthcare professionals.

The first Integrated Development and Manufacturing Organization (IDMO) for cell therapies.

Pioneering vision restoration therapies for severe retinal degenerations.

Developing microbiome-based therapeutics to address underlying disease biology, particularly in gastrointestinal health.

Unleashing the power of genomics at scale for biological advances and human health.

Develops and commercializes a novel cancer treatment technology called Alpha DaRT.

Clinical-stage biopharmaceutical company developing novel boron-based small molecule therapeutics for rare infectious diseases and oncology.

Develops long-acting implantable and injectable therapies for opioid addiction and chronic pain.

AI-driven digital twin of embryo development for cell-based therapies.

Biopharmaceutical company developing best-in-class medicines for autoimmune and rare diseases, with a focus on thyroid eye disease.

Developing microbiome-derived therapies to overcome resistance to immune checkpoint inhibitors in cancer treatment.

Biopharmaceutical company developing targeted neutrophil nanoparticle platform for chronic diseases.

Clinical-stage biotech developing a monoclonal antibody targeting TSLP for inflammatory diseases.

Dot Compliance provides an AI-powered eQMS for life sciences companies to accelerate product delivery and reduce costs.

Global transport technology for living cells.

AI-powered platform for developing lipid nanoparticles for oligonucleotide therapies.

Empowering pharmaceutical researchers with advanced molecular understanding.

Biotech company developing a novel drug delivery platform using cell membrane-derived nanoparticles.

Advanced infectious disease diagnostics

AI-powered patient-centric drug simulations to accelerate and de-risk drug development.

Computational platform using LLMs trained on biological and chemical data for drug discovery.

Develops a platform for adaptive clinical trial design and closed-loop execution.

Upcycles food waste into high-value lactic acid using climate-transformative technology.

AI-driven platform for protein-level disease mapping and drug discovery.

AI-powered blood test for early cancer detection and subtyping.

Personalized medicine startup focused on accurate cancer treatment through advanced diagnostics and functional drug sensitivity testing.

Synthetic biology platform for environmental sustainability solutions.

Omnix Medical is developing a novel platform for advanced wound care management.

Develops a platform for individual drug customization using aptamers for cancer treatment.

AI-powered epiproteomic analysis platform for mass spectrometry data.

AI-powered insights platform for life sciences and biotech workflows.

Biopharmaceutical company developing innovative punctal plug technology for eye disease therapies.

Compressing biology to develop the next generation of therapies.

Revolutionizing drug design using quantum computing, AI, and personalized medicine.

Biotechnology company developing potentially curative cell therapies for cancer patients.

Biotech company developing next-generation immunotherapy agents to unlock the immune system.

Developing sex reversal technology for the broiler industry to improve economic efficiency and increase male broiler production.

Stealth mode startup in life sciences and synthetic biology.

Pioneering precision microbiome therapeutics for oncology using CRISPR and synthetic biology.

AI-driven drug discovery spinoff from DeepMind using AlphaFold to discover novel medicines.

Develops autologous engineered tissue from omentum biopsies for medical conditions.

AI platform for discovering complex multi-omics signatures for personalized medicine.

Clinical-stage biotechnology company developing multi-mechanistic oncolytic immunotherapy programs for cancer treatment.

Revolutionizing prenatal testing with non-invasive fetal DNA analysis from maternal blood.

Genocure AI is developing AI-powered solutions for oncology drug discovery and development.

Independent investment company and venture builder partnering with the University of Oxford to build businesses.

Synthetic biology startup optimizing gene expression for food and biotech applications.

Cloud-based platform for reproducible computational research in life sciences.